Pregnancy-associated plasma protein A as an independent mortality predictor in long-term hemodialysis patients

Kidney and Blood Pressure Research

Volumn 35, Issue 3, 2012, Pages 192-201

  Kalousová, Marta ^a   Benáková, Hana ^a   Kuběna, Aleš Antonín ^a   Dusilová Sulková, Sylvie ^b   Tesař, Vladimír ^a   Zima, Tomáš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Cardiovascular mortality; Hemodialysis; Infection; Mortality; Pregnancy associated plasma protein A

Indexed keywords

GELATINASE A; GELATINASE B; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; INTERSTITIAL NEPHRITIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RENOVASCULAR HYPERTENSION;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 82055178471     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000332086     Document Type: Article

References (37)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-S119. (Pubitemid 28527268)
2. Bayes-Genis A, Conover CA, Overgaard MT, et al: Pregnancy-associated plasma protein A as marker of acute coronary syndromes. N Engl J Med 2001; 345: 1057-1059.
3. Wald NJ, Kennard A, Hackshaw AK: First trimester serum screening for Down's syndrome. Prenat Diagn 1995; 15: 1227-1240. (Pubitemid 26060627)
4. Bonno M, Oxvig C, Kephart GM, et al: Localization of pregnancy-associated plasma protein-A and colocalization of pregnancyassociated protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 1994; 71: 560-566. (Pubitemid 24338164)
5. Overgaard MT, Oxvig C, Christiansen M, et al: Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. Biol Reprod 1999; 61: 1083-1089. (Pubitemid 29455648)
6. Lawrence JB, Oxvig C, Overgaard MT, et al: The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts in pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999; 96: 3149-3153. (Pubitemid 29148859)
7. Laursen LS, Overgaard MT, Soe R, et al: Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 2001; 504: 36-40. (Pubitemid 32777807)
8. Monget P, Mazerbourg S, Delpuech T, et al: Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol Reprod 2003; 68: 77-86. (Pubitemid 36076321)
9. Jones JI, Prevette T, Gockerman A, Clemmons DR: Ligand occupancy of the Vf3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci USA 1996; 93: 2482-2487. (Pubitemid 26104797)
10. Renier G, Clement I, Desfaits AC, Lambert A: Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-production. Endocrinology 1996; 137: 4611-4618. (Pubitemid 26403296)
11. Conti E, Andreotti F, Zuppi C: Pregnancyassociated plasma protein a as predictor of outcome in patients with suspected acute coronary syndromes. Circulation 2004; 109: e211-e212.
12. Lund J, Ruin QP, Ilva T, et al: Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but not troponin I elevation. Circulation 2003; 108: 1924-1926. (Pubitemid 37296534)
13. Kalousová M, Sulková S, Fialová L, et al: Glycoxidation and inflammation in chronic hemodialysis patients. Nephrol Dial Transplant 2003; 18: 2577-2581. (Pubitemid 37483791)
14. Fialová L, Kalousová M, Soukupová J, et al: Relationship of pregnancy-associated plasma protein A to renal function and dialysis modalities. Kidney Blood Press Res 2004; 27: 88-95. (Pubitemid 38594560)
15. Kalousová M, Bartošová K, Zima T, Skibová J, Teplan V, Viklický O: Pregnancy-associated plasma protein A and soluble receptor for advanced glycation end products after kidney transplantation. Kidney Blood Press Res 2007; 30: 31-37.
16. Kalousová M, Hoejší M, Fialová L, et al: Increased levels of pregnancy-associated plasma protein A are associated with mortality of haemodialysis patients: preliminary results. Blood Purif 2004; 22: 298-300. (Pubitemid 39177735)
17. Etter C, Straub Y, Hersberger M, et al: Pregnancy-associated plasma protein A is an independent short-time predictor of mortality in patients on maintenance haemodialysis. Eur Heart J 2010; 31: 354-359.
18. Lauzurica R, Pastor C, Bayes B, Hernandez JM, Romero M: Pretransplant pregnancyassociated plasma protein-A as a predictor of chronic allograft nephropathy and posttransplant cardiovascular events. Transplantation 2005; 80: 1441-1446. (Pubitemid 41803627)
19. Apple FS, Wu AH, Mair J, et al: Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005; 51: 810-824. (Pubitemid 40577917)
20. Kalousová M, Kub̈na AA, Koštíová M, et al: Lower retinol as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis 2010; 6: 513-521.
21. Heeschen C, Dimmeler S, Hamm CW, Fichtischerer S, Simoons ML, Zeiher AM, CAPTURE Study Investigators: Pregnancy-associated plasma protein A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005; 45: 229-237. (Pubitemid 40094730)
22. Elesber AA, Conover CA, Denktas AE, et al: Prognostic value of circulating pregnancyassociated plasma protein levels in patients with chronic stable angina pectoris. Eur Heart J 2006; 27: 1678-1684. (Pubitemid 44025354)
23. Mueller T, Dieplinger B, Forstner T, Poelz W, Haltmayer M: Pregnancy-associated plasma protein A as a marker for long-term mortality in patients with peripheral atherosclerosis: inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study. Clin Chem Lab Med 2010; 48: 537-542.
24. Astrup AS, Tarnow L, Christiansen M, Hansen PR, Parving HH, Rossing P: Pregnancyassociated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective followup study. Diabet Med 2007; 24: 1381-1385. (Pubitemid 350179437)
25. Lauzuriza R, Pastor MC, Bayes B, et al: Pretransplant inflammation: a risk factor for delayed graft function? J Nephrol 2008; 21: 221-228.
26. Resch ZT, Chen BK, Bale LK, Oxvig C, Overgaard MT, Conover CA: Pregnancy-associated plasma protein a gene expression as a target of inflammatory cytokines. Endocrinology 2004; 145: 1124-1129. (Pubitemid 38280991)
27. Conover CA, Harrington SC, Bale LK: Differential regulation of pregnancy-associated plasma protein A in human coronary artery endothelial cells and smooth muscle cells. Growth Horm IGF Res 2008; 18: 213-220. (Pubitemid 351479925)
28. Conover CA, Bale LK, Harrington SC, Resch ZT, Overgaard MT, Oxvig C: Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. Am J Physiol Cell Physiol 2006; 290: C183-C188.
29. Crea F, Andreotti F: Pregnancy-associated plasma protein-A and coronary atherosclerosis: marker, friend or foe? Eur Heart J 2005; 26: 2075-2076.
30. Conti E, Carrozza C, Capoluongo E, et al: Insulin-like growth factor-1 as vascular protective factor. Circulation 2004; 110: 2260-2265. (Pubitemid 39372511)
31. Watanabe S, Tamura T, Ono K, et al: Insulinlike growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin. Eur J Heart Fail 2010; 12: 1214-1222.
32. Andreassen M, Kistorp C, Raymond I, et al: Plasma insulin-like growth factor I as predictor of progression and all-cause mortality in chronic heart failure. Growth Horm IGF Res 2009; 19: 486-490.
33. Kumar A, Mohan S, Newton J, et al: Pregnancy-associated plasma protein A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism. J Biol Chem 2005; 280: 37782-37789. (Pubitemid 41642388)
34. Conover CA, Mason MA, Bale LK, et al: Transgenic overexpression of pregnancy-associated plasma protein A in murine arterial smooth muscle accelerates atherosclerotic lesion development. Am J Physiol Heart Circ Physiol 2010; 299:H284-H291.
35. Lenderink T, Heeschen C, Fichtlscherer S, et al: CAPTURE Investigators: Elevated placental growth factor levels are associated with adverse outcomes at four-year followup in patients with acute coronary syndromes. J Am Coll Cardiol 2006; 47: 307-311. (Pubitemid 43063247)
36. Dhillon OS, Khan SQ, Narayan HK, et al: Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome. Clin Sci (Lond) 2009; 118: 249-257.
37. Ye YX, Leu HB, Wu TC, Lin SJ, Chen JW: Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease. Clin Biochem 2008; 41: 292-298.